A novel AKT inhibitor, AZD5363, inhibits phosphorylation of AKT downstream molecules, and activates phosphorylation of mTOR and SMG-1 dependent on the liver cancer cell typeYuncheng Zhang, Jun Liu|Oncology Letters|2016Cited by 29